Want to see SE:NNH full AI Analyst Report?
New Nordic Healthbrands AB (NNH) Stock Statistics & Valuation Metrics
Total Valuation
New Nordic Healthbrands AB has a market cap or net worth of SEK 92.62M. The enterprise value is SEK 139.27M.
- Market Cap
- SEK 92.62M
- Enterprise Value
- SEK 139.27M
Share Statistics
New Nordic Healthbrands AB has 6,195,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 6,195,200
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
New Nordic Healthbrands AB’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 7.12%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 7.12%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 7.12M
- Profits Per Employee
- 101.17K
- Employee Count
- 81
- Asset Turnover
- 2.34
- Inventory Turnover
- 5.38
Valuation Ratios
The current PE Ratio of New Nordic Healthbrands AB is 19.80. New Nordic Healthbrands AB’s PEG ratio is -0.46.
- PE Ratio
- 19.80
- PS Ratio
- 0.15
- PB Ratio
- 0.84
- Price to FCF
- 1487.86
- Price to Operating Cash Flow
- 1375.15
- PEG Ratio
- -0.46
Income Statement
In the last 12 months, New Nordic Healthbrands AB had revenue of 576.36M and earned 8.20M in profits. Earnings per share was 1.32.
- Revenue
- 576.36M
- Gross Profit
- 15.95M
- Operating Income
- 15.15M
- Pretax Income
- 12.51M
- Net Income
- 8.20M
- EBITDA
- 17.61M
- Earnings Per Share (EPS)
- 1.32
Cash Flow
In the last 12 months, operating cash flow was 66.00K and capital expenditures -5,000, giving a free cash flow of 61.00K billion.
- Operating Cash Flow
- 66.00K
- Free Cash Flow
- 61.00K
- Free Cash Flow per Share
- 0.01
Dividends & Yields
New Nordic Healthbrands AB pays an annual dividend of SEK 0.25, resulting in a dividend yield of 1.71%
- Dividend Per Share
- SEK 0.25
- Dividend Yield
- 1.71%
- Payout Ratio
- 57.87%
- Free Cash Flow Yield
- 0.07%
- Earnings Yield
- 4.99%
Stock Price Statistics
- Beta
- 0.32
- 52-Week Price Change
- -34.60%
- 50-Day Moving Average
- 17.50
- 200-Day Moving Average
- 16.37
- Relative Strength Index (RSI)
- 29.55
- Average Volume (3m)
- 9,551
Important Dates
New Nordic Healthbrands AB upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 23, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- Apr 30, 2026
Financial Position
New Nordic Healthbrands AB as a current ratio of 1.60, with Debt / Equity ratio of 34.64%
- Current Ratio
- 1.60
- Quick Ratio
- 0.85
- Debt to Market Cap
- 0.25
- Net Debt to EBITDA
- 1.10
- Interest Coverage Ratio
- 5.65
Taxes
In the past 12 months, New Nordic Healthbrands AB has paid 4.32M in taxes.
- Income Tax
- 4.32M
- Effective Tax Rate
- 0.35
Enterprise Valuation
New Nordic Healthbrands AB EV to EBITDA ratio is 8.46, with an EV/FCF ratio of 1993.60.
- EV to Sales
- 0.21
- EV to EBITDA
- 8.46
- EV to Free Cash Flow
- 1993.60
- EV to Operating Cash Flow
- 1842.57
Balance Sheet
New Nordic Healthbrands AB has SEK 7.29M in cash and marketable securities with SEK 38.15M in debt, giving a net cash position of -SEK 30.85M billion.
- Cash & Marketable Securities
- SEK 7.29M
- Total Debt
- SEK 38.15M
- Net Cash
- -SEK 30.85M
- Net Cash Per Share
- -SEK 4.98
- Tangible Book Value Per Share
- SEK 16.40
Margins
Gross margin is 16.23%, with operating margin of 1.98%, and net profit margin of 0.77%.
- Gross Margin
- 16.23%
- Operating Margin
- 1.98%
- Pretax Margin
- 1.70%
- Net Profit Margin
- 0.77%
- EBITDA Margin
- 2.43%
- EBIT Margin
- 1.98%
Analyst Forecast
The average price target for New Nordic Healthbrands AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.70%
- EPS Growth Forecast
- -43.94%
Scores
- Smart Score
- ―
- AI Score
- 51
